Wolverine Trading, LLC Fulgent Genetics, Inc. Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$47.98 - $62.75 $180,356 - $235,877	-3,759 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $347,653 - $670,271	-6,974 Reduced 64.98%	3,759 $235,000
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $663,234 - $900,900	-8,580 Reduced 44.43%	10,733 $1.09 Million
Q1 2021 May 14, 2021	SELL	$59.3 - $183.85 $48,151 - $149,286	-812 Reduced 4.03%	19,313 $1.78 Million
Q4 2020 Feb 12, 2021	BUY	$31.01 - $52.1 $624,076 - $1.05 Million	20,125 New	20,125 $1.02 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $541M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.